PharmaBoardroom

COVID-19 and the Brazilian Pharma Supply Chain

The editorial team at Panorama Farmaceutico explain how the COVID-19 pandemic and global trade flow stoppages are impacting the manufacture and supply…

EFPIA’s Nathalie Moll on COVID-19 & the Future of…

In a recent exclusive conversation with PharmaBoardroom, Nathalie Moll, director general of the European Federation of Pharmaceutical Industries &…

Company Spotlight: JLABS @ Shanghai

Johnson & Johnson’s network of healthcare innovation incubators, JLABS, opened its doors in Shanghai in June 2019 and now stands as the largest…

European Pharma Mid-Caps’ US Strategies: Complexity, Scale,…

Three US country managers for European pharma mid-caps explain the challenges in setting up an American affiliate, as well as how best to capitalise…

Albert Yu – Chairman, Hong Kong Biotechnology Organization…

Dr Albert Yu, chairman of the Hong Kong Biotechnology Organization (HKBIO) gives his expert insights into the crucial importance of diagnostics in…

Constanza Losada – President & CEO, Pfizer Mexico

Recently appointed CEO and president for Pfizer Mexico, Constanza Losada, outlines the exciting challenge of taking on leadership for such an…

Pierre A Morgon – SVP International Business, CanSino…

Pierre A Morgon, SVP International Business for CanSino Biotechnology (CanSinoBIO) – a Chinese vaccine biotech developing one of the frontrunner…

Peking University’s Potential COVID-19 Cure

Highly potent neutralizing antibodies may be the key to laying a foundation for COVID-19 treatment, according to a Chinese research team led by Peking…

Pfizer’s COVID-19 Vaccine: A Unique Approach

At the 28 May 2020 IFPMA media briefing on COVID-19 vaccines, Pfizer chairman and CEO Dr Albert Bourla outlined why the US firm had decided to take a…